Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines

Go back to Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.12 --0 (-0%)
Previous Close $2.12    52 Week High $3.64 
Open $2.12    52 Week Low $0.14 
Day High $2.12    P/E N/A 
Day Low $2.12    EPS $0.00 
Volume 986